EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 28-Oct-2026 04:16 ET (28-Oct-2026 08:16 GMT/UTC)

MSU scientists uncover how ovarian cancer resists chemotherapy — and how to reverse it

Michigan State University
Peer-Reviewed Publication

Michigan State University researchers have identified how ovarian cancer cells become resistant to chemotherapy and discovered a protein, that, when blocked, can restore the drug’s effectiveness.

Journal: Cell Reports

Beyond the “magic bullet”: scientists map how cancer outsmarts antibody-drug conjugates—and how to fight back

China Anti-Cancer Association
Peer-Reviewed Publication

Antibody-drug conjugates (ADCs) are among the most promising advances in modern oncology—precision-guided missiles that deliver potent cytotoxic agentsdirectly to cancer cells while sparing healthy tissue.

Journal: Cancer Biology & Medicine

Right versus left: Colorectal cancer's two microbial worlds

China Anti-Cancer Association
Peer-Reviewed Publication

The microbial landscape of colorectal cancer is far more complex than previously thought, with tumors on opposite sides of the colon harboring distinctly different bacterial communities.

Journal: Cancer Biology & Medicine

Microbes rewrite the rules of cancer immunotherapy by triggering immunogenic cell death

China Anti-Cancer Association
Peer-Reviewed Publication

A new study reveals that microbiota and their metabolites can effectively reprogram immunogenic cell death (ICD), a unique form of cell death that activates the body‘s immune system against tumors.

Journal: Cancer Biology & Medicine

New alliance study tests immunotherapy to prevent lung cancer recurrence

Alliance for Clinical Trials in Oncology
Business Announcement

The Alliance for Clinical Trials in Oncology has launched a new national study to see if an immune-boosting drug can help keep early-stage lung cancer from coming back after surgery. Alliance A082302 aims to enroll 336 participants in this phase III trial specifically focusing on patients with stage I non-small cell lung cancer.

Funder: Alliance for Clinical Trials in Oncology

AACR releases Cancer Disparities Progress Report 2026

American Association for Cancer Research
Reports and Proceedings

The American Association for Cancer Research (AACR) today released its Cancer Disparities Progress Report 2026, a comprehensive analysis of the unequal burden of cancer in the United States. First published in 2020, this biennial report highlights the progress being made against cancer disparities while also raising awareness of the disproportionate toll that cancer continues to exact on racial and ethnic minority groups and other medically underserved populations, including sexual and gender minorities and residents of rural areas and persistent-poverty regions.

The role of TP53 mutations in oral cancer: molecular mechanisms and prognostic implications

ELSP
Peer-Reviewed Publication

A comprehensive review highlights how TP53 mutations contribute to oral cancer development, treatment resistance, and poor patient outcomes. The study summarizes emerging therapeutic approaches, including mutant p53 reactivation, synthetic lethality, and immunotherapy-based strategies, providing new perspectives for precision medicine in oral cancer.A comprehensive review highlights how TP53 mutations contribute to oral cancer development, treatment resistance, and poor patient outcomes. The study summarizes emerging therapeutic approaches, including mutant p53 reactivation, synthetic lethality, and immunotherapy-based strategies, providing new perspectives for precision medicine in oral cancer.

Journal: Advanced Cancer Research

Sugar-coated nanoparticles show promise for treating most aggressive form of brain cancer

Oregon State University
Peer-Reviewed Publication

Researchers at Oregon State University have potentially found a new way to treat the most aggressive form of brain cancer, glioblastoma, whose two-year survival rate is less than 30%.

Journal: Journal of Controlled Release
Funder: National Research Foundation of Korea

Contagious cancer likely crossed an ocean, triggering severe outbreak in Pacific Northwest clams

Pacific Northwest Research Institute
Peer-Reviewed Publication

A rare contagious cancer has triggered a severe outbreak in soft-shell clams in Washington state's Puget Sound after likely being introduced from Atlantic Coast populations. Researchers also developed an environmental DNA tool to detect and track the disease in seawater, creating a new way to monitor emerging marine diseases and study the evolution of cancer resistance in wild populations.

Journal: Proceedings of the National Academy of Sciences

Rice bioengineer wins federal award for Ewing sarcoma research

Rice University
Grant and Award Announcement

Rice bioengineer Julea Vlassakis has won $1.1M in federal funding for a project researching Ewing sarcoma.